Allarity Therapeutics Inc... (ALLR)
Allarity Therapeutics Statistics
Share Statistics
Allarity Therapeutics has 17.01M shares outstanding. The number of shares has increased by -82.67% in one year.
Shares Outstanding | 17.01M |
Shares Change (YoY) | -82.67% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 19.14% |
Shares Floating | 13M |
Failed to Deliver (FTD) Shares | 417 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.2M, so 7.05% of the outstanding shares have been sold short.
Short Interest | 1.2M |
Short % of Shares Out | 7.05% |
Short % of Float | 7.05% |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.02. Allarity Therapeutics's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -0.02 |
PS Ratio | 0 |
Forward PS | 0.2 |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Allarity Therapeutics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.11.
Current Ratio | 2.06 |
Quick Ratio | 2.06 |
Debt / Equity | 0.11 |
Debt / EBITDA | -0.05 |
Debt / FCF | -0.08 |
Interest Coverage | 41.72 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-4.09M |
Employee Count | 6 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -381K |
Effective Tax Rate | 1.53% |
Stock Price Statistics
The stock price has increased by -97.97% in the last 52 weeks. The beta is -0.07, so Allarity Therapeutics's price volatility has been lower than the market average.
Beta | -0.07 |
52-Week Price Change | -97.97% |
50-Day Moving Average | 0.93 |
200-Day Moving Average | 2.25 |
Relative Strength Index (RSI) | 54.39 |
Average Volume (20 Days) | 2.37M |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -27.24M |
Net Income | -24.52M |
EBITDA | -27.24M |
EBIT | -25.55M |
Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 19.53M in cash and 1.35M in debt, giving a net cash position of 18.18M.
Cash & Cash Equivalents | 19.53M |
Total Debt | 1.35M |
Net Cash | 18.18M |
Retained Earnings | -118.97M |
Total Assets | 22.65M |
Working Capital | 11.5M |
Cash Flow
In the last 12 months, operating cash flow was -17.35M and capital expenditures -298K, giving a free cash flow of -17.65M.
Operating Cash Flow | -17.35M |
Capital Expenditures | -298K |
Free Cash Flow | -17.65M |
FCF Per Share | 0 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ALLR.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 11, 2024. It was a backward split with a ratio of 1:30.
Last Split Date | Sep 11, 2024 |
Split Type | backward |
Split Ratio | 1:30 |
Scores
Altman Z-Score | -9.66 |
Piotroski F-Score | 3 |